STOCKHOLM, Nov. 23, 2020 /PRNewswire/ -- On
November 25th, 2020, at
02:00 am (CET), investors, analysts
and journalists are invited to participate in a digital company
presentation. Moberg pharma recently announced its intention to
distribute its subsidiary OncoZenge through a Lex ASEA distribution
before listing the company on Nasdaq First North Growth Market, as
well as securing financing both for OncoZenge and Moberg
Pharma.
The teleconference will be hosted by Moberg Pharmas's CEO
Anna Ljung and Chairman of the Board
Peter Wolpert. The presentation will be held in Swedish.
Date: Wednesday November
25th, 2020
Time: 12:00 am - 1:00 pm
(CET)
To participate in the conference, please use the following
link:
https://zoom.us/webinar/register/WN_EQZwZq8dTiugFJjacf7IeQ
Presentation material will be made public on:
http://www.mobergpharma.com/investors/calendarpresentations
For additional information, please contact:
Anna Ljung, CEO, Phone: + 46
70 766 60 30, e-post: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance,
Phone: + 46 76 805 82 88, e-post:
mark.beveridge@mobergpharma.se
This information was brought to you by Cision
http://news.cision.com
The following files are available for download:
|
https://mb.cision.com/Main/1662/3241533/1338425.pdf
|
Invitation to market
update in Moberg Pharma on November 25th
|
View original
content:http://www.prnewswire.com/news-releases/invitation-to-market-update-in-moberg-pharma-on-november-25th-301178698.html
SOURCE Moberg Pharma